CuraMend

CuraMendCuraMend

CuraMend

High authorityStealth modeStealth Mode

Pioneering AI-integrated diagnostics and holistic therapies for preventive and personalized healthcare.

2026Active

About

Curamend Healthcare, led by Dr. Sunil Saldanha, is transforming global health by synergizing artificial intelligence with bio-resonance therapy, regenerative medicine, AYUSH-based therapies, and emotional healing techniques. The company focuses on identifying and treating the root cause of diseases through non-invasive, AI-driven diagnostics and personalized treatment protocols, aiming to prevent illnesses before they fully develop and improve long-term health outcomes.
Frequently asked

What does CuraMend do?

Curamend Healthcare, led by Dr. Sunil Saldanha, is transforming global health by synergizing artificial intelligence with bio-resonance therapy, regenerative medicine, AYUSH-based therapies, and emotional healing techniques. The company focuses on identifying and treating the root cause of diseases through non-invasive, AI-driven diagnostics and personalized treatment protocols, aiming to prevent illnesses before they fully develop and improve long-term health outcomes.

When was CuraMend founded?

CuraMend was founded in 2026.

What industry does CuraMend operate in?

CuraMend operates in HealthTech, MedTech, AI-Driven Protein Design, Preventive Healthcare, Regenerative Medicine, Biotech.

Scores
Measured, not editorial
Agent Readiness
25/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Scan this site yourself
Domain Rating
94/100

Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.

Check any domain free

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.